Cardan Capital Partners’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $4.09M | Buy |
89,900
+21,230
| +31% | +$966K | 0.46% | 70 |
|
|
2021
Q2 | $3.36M | Sell |
68,670
-322
| -0.5% | -$15.8K | 0.37% | 83 |
|
|
2021
Q1 | $3.47M | Buy |
68,992
+16,272
| +31% | +$818K | 0.42% | 75 |
|
|
2020
Q4 | $2.7M | Buy |
52,720
+2,555
| +5% | +$131K | 0.33% | 84 |
|
|
2020
Q3 | $2.06M | Sell |
50,165
-7,419
| -13% | -$305K | 0.27% | 104 |
|
|
2020
Q2 | $2.41M | Buy |
57,584
+11,668
| +25% | +$488K | 0.34% | 94 |
|
|
2020
Q1 | $1.46M | Sell |
45,916
-26,338
| -36% | -$835K | 0.24% | 90 |
|
|
2019
Q4 | $3.06M | Buy |
72,254
+4,887
| +7% | +$207K | 0.41% | 67 |
|
|
2019
Q3 | $2.13M | Buy |
67,367
+11,840
| +21% | +$374K | 0.3% | 82 |
|
|
2019
Q2 | $2.01M | Buy |
55,527
+6,403
| +13% | +$231K | 0.3% | 77 |
|
|
2019
Q1 | $1.78M | Buy |
+49,124
| New | +$1.78M | 0.29% | 76 |
|